Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes

American Journal of Human Genetics

Volumn 78, Issue 3, 2006, Pages 423-436

  Patin, Etienne ^a,c   Barreiro, Luis B ^a   Sabeti, Pardis C ^d   Austerlitz, Frédéric ^e   Luca, Francesca ^f   Sajantila, Antti ^g   Behar, Doron M ^h   Semino, Ornella ⁱ   Sakuntabhai, Anavaj ^b   Guiso, Nicole ^a   Gicquel, Brigitte ^b   McElreavey, Ken ^b   Harding, Rosalind M ^j   Heyer, Evelyne ^c   Quintana Murci, Lluís ^a,b  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c MUSÉE DE L HOMME   (France)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f UNIVERSITY OF CALABRIA   (Italy)

^g UNIVERSITY OF HELSINKI   (Finland)

^h RAMBAM MEDICAL CENTER   (Israel)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; XENOBIOTIC AGENT;

ACETYLATION; ACETYLATOR PHENOTYPE; ARTICLE; BLADDER CANCER; CANCER SUSCEPTIBILITY; DEMOGRAPHY; ETHNIC DIFFERENCE; EVOLUTIONARY ADAPTATION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; NAT1 GENE; NAT2 GENE; NATURAL SELECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOGENE; UNINDEXED SEQUENCE;

EID: 33344457433     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/500614     Document Type: Article

References (95)

1. Asprodini EK, Zifa E, Papageorgiou I, Benakis A (1998) Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe. Eur J Drug Metab Pharmacokinet 23:501-506
2. Austerlitz F, Kalaydjieva L, Heyer E (2003) Detecting population growth, selection and inherited fertility from haplotypic data in humans. Genetics 165:1579-1586
3. Barreiro LB, Patin E, Neyrolles O, Cann HM, Gicquel B, Quintana-Murci L (2005) The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region. Am J Hum Genet 77:869-886
4. Behar DM, Hammer MF, Garrigan D, Villems R, Bonne-Tamir B, Richards M, Gurwitz D, Rosengarten D, Kaplan M, Pergola SD, Quintana-Murci L, Skorecki K (2004) MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Eur J Hum Genet 12:355-364
5. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, Rhodes M, Reich DE, Hirschhorn JN (2004) Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 74:1111-1120
6. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203
7. Bozkurt A, Basci NE, Kalan S, Tuncer M, Kayaalp SO (1990) N-acetylation phenotyping with sulphadimidine in a Turkish population. Eur J Clin Pharmacol 38:53-56
8. Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Hubisz MT, Glanowski S, Tanenbaum DM, White TJ, Sninsky JJ, Hernandez RD, Civello D, Adams MD, Cargill M, Clark AG (2005) Natural selection on protein-coding genes in the human genome. Nature 437:1153-1157
9. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, Kahn M (1982) A role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-846
10. Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I (1995) Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57:581-592
11. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81:341-354
12. Cornuet JM, Luikart G (1996) Description and power analysis of two tests for detecting recent population bottlenecks from allele frequency data. Genetics 144:2001-2014
13. de Leon JH, Vatsis KP, Weber WW (2000) Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1. Mol Pharmacol 58:288-299
14. Eidus L, Hodgkin MM, Schaefer O, Jessamine AG (1974) Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine test. Rev Can Biol 33:117-123
15. El-Yazigi A, Johansen K, Raines DA, Dossing M (1992) N-acetylation polymorphism and diabetes mellitus among Saudi Arabians. J Clin Pharmacol 32:905-910
16. Excoffier L (2002) Human demographic history: refining the recent African origin model. Curr Opin Genet Dev 12:675-682
17. Fay JC, Wu CI (2000) Hitchhiking under positive Darwinian selection. Genetics 155:1405-1413
18. Ferguson LR (2002) Natural and human-made mutagens and carcinogens in the human diet. Toxicology 181-182:79-82
19. Fu YX, Li WH (1993) Statistical tests of neutrality of mutations. Genetics 133:693-709
20. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
21. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tora M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649-659
22. Garrigan D, Mobasher Z, Severson T, Wilder JA, Hammer MF (2005) Evidence for archaic Asian ancestry on the human X chromosome. Mol Biol Evol 22:189-192
23. Griffiths RC, Tavaré S (1994) Sampling theory for neutral alleles in a varying environment. Philos Trans R Soc Lond B Biol Sci 344:403-410
24. Harding RM, McVean G (2004) A structured ancestral population for the evolution of modern humans. Curr Opin Genet Dev 14:667-674
25. Harris DR (ed) (1996) The origins and spread of agriculture and pastoralism in Eurasia. Smithsonian Institution Press, Washington, DC
26. Harris EE, Hey J (1999) X chromosome evidence for ancient human histories. Proc Natl Acad Sci USA 96:3320-3324
27. Hashiguchi M, Ebihara A (1992) Acetylation polymorphism of caffeine in a Japanese population. Clin Pharmacol Ther 52:274-276
28. Hayakawa T, Aki I, Varki A, Satta Y, Takahata N (2005) Fixation of the human-specific CMP-N-acetylneuraminic acid hydroxylase pseudogene and implications of haplotype diversity for human evolution. Genetics (http://www.genetics.org/cgi/rapidpdf/genetics.105 .046995v1) (electronically published November 4, 2005; accessed January 12, 2006)
29. Hein DW (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506-507:65-77
30. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29-42
31. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29-42
32. Hill WG, Robertson A (1968) The effects of inbreeding at loci with heterozygote advantage. Genetics 60:615-628
33. Hodgkin MM, Eidus L, Bailey WC (1979) Isoniazid phenotyping of black as well as white patients. Can J Physiol Pharmacol 57:760-763
34. Hombhanje F (1990) An assessment of acetylator polymorphism and its relevance in Papua New Guinea. P N G Med J 33:107-110
35. Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY, Chang FY, Lee SD (2002) Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 35:883-889
36. Hudson RR (2002) Generating samples under a Wright-Fisher neutral model. Bioinformatics 18:337-338
37. Hudson RR, Kreitman M, Aguade M (1987) A test of neutral molecular evolution based on nucleotide data. Genetics 116:153-159
38. Hughes NC, Janezic SA, McQueen KL, Jewett MA, Castranio T, Bell DA, Grant DM (1998) Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 8:55-66
39. Ilett KF, Chiswell GM, Spargo RM, Platt E, Minchin RF (1993) Acetylation phenotype and genotype in Aboriginal leprosy patients from the north-west region of western Australia. Pharmacogenetics 3:264-269
40. Innan H (2003) A two-locus gene conversion model with selection and its application to the human RHCE and RHD genes. Proc Natl Acad Sci USA 100:8793-8798
41. Irshaid Y, al-Hadidi H, Abuirjeie M, Latif A, Sartawi O, Rawashdeh N (1992) Acetylator phenotypes of Jordanian diabetics. Eur J Clin Pharmacol 43:621-623
42. Jeffreys AJ, May CA (2004) Intense and highly localized gene conversion activity in human meiotic crossover hot spots. Nat Genet 36:151-156
43. Jeyakumar LH, French MR (1981) Polymorphic acetylation of sulfamethazine in a Nigerian (Yoruba) population. Xenobiotica 11:319-321
44. Jorge-Nebert LF, Eichelbaum M, Griese EU, Inaba T, Arias TD (2002) Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Pharmacogenetics 12:39-48
45. Karim AK, Elfellah MS, Evans DA (1981) Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution. J Med Genet 18:325-330
46. Kimura M (1968) Evolutionary rate at the molecular level. Nature 217:624-626
47. Kukongviriyapan V, Lulitanond V, Areejitranusorn C, Kongyingyose B, Laupattarakasem P (1984) N-acetyltransferase polymorphism in Thailand. Hum Hered 34:246-249
48. Labuda D, Zietkiewicz E, Labuda M (1997) The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim. Am J Hum Genet 61:768-771
49. Lee SY, Lee KA, Ki CS, Kwon OJ, Kim HJ, Chung MP, Suh GY, Kim JW (2002) Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Clin Chem 48:775-777
50. Lewin R (1987) Africa: cradle of modern humans. Science 237:1292-1295
51. Lewontin RC (1964) The interaction of selection and linkage. II. Optimum models. Genetics 50:757-782
52. Lil'in ET, Korsunskaia MP, Meksin VA, Drozdov ES, Nazarov VV (1984) Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism. Genetika 20:1557-1559
53. Marth G, Schuler G, Yeh R, Davenport R, Agarwala R, Church D, Wheelan S, Baker J, Ward M, Kholodov M, Phan L, Czabarka E, Murvai J, Cutler D, Wooding S, Rogers A, Chakravarti A, Harpending HC, Kwok PY, Sherry ST (2003) Sequence variations in the public human genome data reflect a bottlenecked population history. Proc Natl Acad Sci USA 100:376-831
54. McDonald JH, Kreitman M (1991) Adaptive protein evolution at the Adh locus in Drosophila. Nature 351:652-654
55. Neel JV (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14:353-362
56. Nei M (ed) (1987) Molecular evolutionary genetics. Columbia University Press, New York
57. Nhachi CF (1988) Polymorphic acetylation of sulphamethazine in a Zimbabwe population. J Med Genet 25:29-31
58. Ong ML, Mant TG, Veerapen K, Fitzgerald D, Wang F, Manivasagar M, Bosco JJ (1990) The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a Southeast Asian population: a study of Indians, Malays and Malaysian Chinese. Br J Rheumatol 29:462-464
59. Pääbo S (2003) The mosaic that is our genome. Nature 421:409-412
60. Przeworski M, Hudson RR, Di Rienzo A (2000) Adjusting the focus on human variation. Trends Genet 16:296-302
61. Reeve JP, Rannala B (2002) DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 18:894-895
62. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R (2003) DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497
63. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler D, Cooper R, Kwiatkowski D, Ward R, Lander ES (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419:832-837
64. Saleem M, Malik SA, Ahmed M, Saleem N (1989) Isoniazid acetylation and polymorphism in humans. J Pak Med Assoc 39:285-286
65. Sardas S, Lahijany B, Cok I, Karakaya AE (1993) N-acetylation phenotyping with sulfumethazine in an Iranian population. Pharmacogenetics 3:131-134
66. Saunders MA, Slatkin M, Garner C, Hammer MF, Nachman MW (2005) The span of linkage disequilibrium caused by selection on G6PD in humans. Genetics 171:1219-1229
67. Schaffner SF, Foo C, Gabriel S, Reich D, Daly MJ, Altshuler D (2005) Calibrating a coalescent simulation of human genome sequence variation. Genome Res 15:1576-1583
68. Schneider S, Roessli D, Excoffier L (2000) Arlequin version 2.000: a software for population genetic data analysis. Genetics and Biometry Laboratory, University of Geneva, Geneva
69. Sebastiani P, Lazarus R, Weiss ST, Kunkel LM, Kohane IS, Ramoni MF (2003) Minimal haplotype tagging. Proc Natl Acad Sci USA 100:9900-9905
70. Sim E, Payton M, Noble M, Minchin R (2000) An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eukaryotes and prokaryotes. Hum Mol Genet 9:2435-2441
71. Slatkin M, Bertorelle G (2001) The use of intraallelic variability for testing neutrality and estimating population growth rate. Genetics 158:865-874
72. Slatkin M, Rannala B (1997) Estimating the age of alleles by use of intraallelic variability. Am J Hum Genet 60:447-458
73. Soranzo N, Bufe B, Sabeti PC, Wilson JF, Weale ME, Marguerie R, Meyerhof W, Goldstein DB (2005) Positive selection on a high-sensitivity allele of the human bitter-taste receptor TAS2R16. Curt Biol 15:1257-1265
74. Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169
75. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595
76. Takahashi M, Matsuda F, Margetic N, Lathrop M (2003) Automated identification of single nucleotide polymorphisms from sequencing data. J Bioinform Comput Biol 1:253-265
77. Takahata N (1993) Allelic genealogy and human evolution. Mol Biol Evol 10:2-22
78. Takahata N, Lee SH, Satta Y (2001) Testing multiregionality of modern human origins. Mol Biol Evol 18:172-183
79. Tang K, Wong LP, Lee EJ, Chong SS, Lee CG (2004) Genomic evidence for recent positive selection at the human MDR1 gene locus. Hum Mol Genet 13:783-797
80. Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, Di Rienzo A (2004) CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet 75:1059-1069
81. Toomajian C, Ajioka RS, Jorde LB, Kushner JP, Kreitman M (2003) A method for detecting recent selection in the human genome from allele age estimates. Genetics 165:287-297
82. Toomajian C, Kreitman M (2002) Sequence variation and haplotype structure at the human HFE locus. Genetics 161:1609-1623
83. Upton A, Johnson N, Sandy J, Sim E (2001) Arylamine N-acetyltransferases: of mice, men and microorganisms. Trends Pharmacol Sci 22:140-146
84. Wang Z, Wang B, Tang K, Lee EJ, Chong SS, Lee CG (2005) A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection. Hum Mol Genet 14:2075-2087
85. Watterson GA (1975) On the number of segregating sites in genetical models without recombination. Theor Popul Biol 7:256-276
86. Weber WW (1987) The acetylator genes and drug response. Oxford University Press, New York
87. Webster MT, Clegg JB, Harding RM (2003) Common 5′ β-globin RFLP haplotypes harbour a surprising level of ancestral sequence mosaicism. Hum Genet 113:123-139
88. Williamson S, Orive ME (2002) The genealogy of a sequence subject to purifying selection at multiple sites. Mol Biol Evol 19:1376-1384
89. Wooding S, Kim UK, Bamshad MJ, Larsen J, Jorde LB, Drayna D (2004) Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 74:637-646
90. Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB (2002) DNA sequence variation in a 3.7-kb noncoding sequence 5′ of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet 71:528-542
91. Woolhouse NM, Qureshi MM, Bastaki SM, Patel M, Abdulrazzaq Y, Bayoumi RA (1997) Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Pharmacogenetics 7:73-82
92. Wright S (ed) (1969) Evolution and the genetics of population. University of Chicago Press, Chicago, p 33
93. Zaid RB, Nargis M, Neelotpol S, Hannan JM, Islam S, Akhter R, Ali L, Azad-Khan AK (2004) Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population data. Biopharm Drug Dispos 25:237-241
94. Zang Y, Zhao S, Doll MA, States JC, Hein DW (2004) The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 14:717-723
95. Zhao B, Seow A, Lee EJ, Lee HP (2000) Correlation between acetylation phenotype and genotype in Chinese women. Eur J Clin Pharmacol 56:689-692